This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for September 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for September 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for August 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Addus HomeCare (ADUS) Q2 Earnings Lag Estimates
by Zacks Equity Research
Addus HomeCare (ADUS) delivered earnings and revenue surprises of -1.96% and 2.68%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for June 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
EVHC vs. ADUS: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EVHC vs. ADUS: Which Stock Is the Better Value Option?
Is a Summer Swoon On the Way?
by John Blank
June is historically a flat month for stocks. Any catalysts this time?
ADUS vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
No Spending Lift from the Consumer? Zacks June Market Strategy
by John Blank
Real Personal Consumption expenditures has been strikingly weak in this recovery. A peak of +3.9% in Real PCE happened in Q1-2015. This growth rate has been sliding down ever since.
What Falling Estimates & Price Mean for Quorum Health (QHC)
by Zacks Equity Research
Quorum Health (QHC) is one stock you should avoid as it has seen a significant price decline and is also seeing negative earnings estimate revisions.
4 Value Stocks for Growth Investors to Enrich Portfolio
by Trina Mukherjee
On the back of an improving economy, we have zeroed in on four value stocks for growth investors, likely to enrich their portfolio.
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
3 Healthcare Stocks Set to Beat Q1 Earnings Estimates
by Zacks Equity Research
Elevated flu activity, aging population, high expenses, and a low tax rate would influence healthcare stocks' earnings in Q1.
Envision Healthcare (EVHC) to Report Q1 Earnings: What's Up?
by Zacks Equity Research
Envision Healthcare's (EVHC) Q1 earnings should see an upside from higher revenues at both its segments.
The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson
Wall Street Brushes Off Trade War Fears: Top 5 Gainers
by Tirthankar Chakraborty
The Dow climbed more than 700 points after investors downplayed fears over tariffs announced by both China and the United States.
Is Addus HomeCare (ADUS) Stock a Solid Choice Right Now?
by Zacks Equity Research
Addus HomeCare (ADUS) could be an interesting play for investors as it is seeing solid earnings estimate revision in addition to having a robust industry rank.
Addus HomeCare (ADUS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Addus HomeCare Corporation (ADUS).
New Strong Sell Stocks for December 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for November 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
The Zacks Analyst Blog Highlights: Malibu Boats, Addus Homecare, Exelixis, Gran Tierra Energy and Delek Logisitcs Partners
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Malibu Boats, Addus Homecare, Exelixis, Gran Tierra Energy and Delek Logisitcs Partners
DaVita Banks on Acquisitions, Escalating Expenses a Concern
by Zacks Equity Research
On Jun 23, we issued an updated research report on Denver, CO-based DaVita HealthCare Partners Inc. (DVA).